RxDoctor Payments Data

David Becker, MD

Gastroenterology · Clearwater, FLNPI 1629151477

Payments from drug & device makers

$16,479in general payments, 2019–2025

Across 330 payments — averaging $49.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$10K
  • AbbVie$2K
  • Johnson & Johnson$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$851
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$444
  • Gilead$335
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$6,57198%
  • Education$1312%
  • Entertainment$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,479 in reported general payments places this provider in the 80th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida

Medicare billing

Part B allowed, 2024
$149,439
Medicare patients
260
Services billed
3,898

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide12$12,581
ClenpiqSod Picosulf/Mag Ox/Citric Ac72$12,439
Fluticasone Propionate HfaFluticasone Propionate15$10,934
VoqueznaVonoprazan Fumarate14$8,761
TrulancePlecanatide12$6,739
Mesalamine15$6,311
Alosetron Hcl13$3,914
Dexlansoprazole DrDexlansoprazole12$3,164
Pantoprazole Sodium191$2,481
Cholestyramine LightCholestyramine20$2,345
Budesonide DrBudesonide32$2,312
Esomeprazole Magnesium25$2,261
SutabSod Sulf/Pot Chloride/Mag Sulf13$2,092
CholestyramineCholestyramine (With Sugar)23$1,852
Rabeprazole Sodium22$1,723

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,606$12,58112 claims
Ferring Pharmaceuticals Inc.Clenpiq$40$12,43972 claims
Phathom Pharmaceuticals, Inc.Voquezna$186$8,76114 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$444$6,73912 claims
Braintree Laboratories, Inc.Sutab$21$2,09213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,388 gastroenterology providers in Florida.

Other gastroenterology in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →